Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana	Breast Feeding; Pre-Exposure Prophylaxis (PrEP)	Active, not recruiting	Phase 4	2026-07-30		NCT05986084

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beth Israel Deaconess Medical Center	161
Botswana Harvard AIDS Institute Partnership	7
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	536
ViiV Healthcare	53

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beth Israel Deaconess Medical Center	Boston	United States	462
Botswana Harvard AIDS Institute Partnership	Gaborone	Botswana	1